Tolerys is granted an innovation support from the Office for Economic Affairs (SPECo) of the canton of Vaud

February 26, 2018

As an innovative company, Tolerys will receive a financial incentive from the canton of Vaud to support a feasibility study for a novel anti-inflammatory immunotherapy targeting the treatment of canine atopic dermatitis.